SAN

82.45

-1.14%↓

UCB

265

+0.3%↑

SHL.DE

36.08

-1.77%↓

ARGX

641.6

+0.63%↑

VIE

33.04

-0.81%↓

SAN

82.45

-1.14%↓

UCB

265

+0.3%↑

SHL.DE

36.08

-1.77%↓

ARGX

641.6

+0.63%↑

VIE

33.04

-0.81%↓

SAN

82.45

-1.14%↓

UCB

265

+0.3%↑

SHL.DE

36.08

-1.77%↓

ARGX

641.6

+0.63%↑

VIE

33.04

-0.81%↓

SAN

82.45

-1.14%↓

UCB

265

+0.3%↑

SHL.DE

36.08

-1.77%↓

ARGX

641.6

+0.63%↑

VIE

33.04

-0.81%↓

SAN

82.45

-1.14%↓

UCB

265

+0.3%↑

SHL.DE

36.08

-1.77%↓

ARGX

641.6

+0.63%↑

VIE

33.04

-0.81%↓

Search

Vetoquinol SA

Atidarymo kaina

SektoriusSveikatos priežiūra

77.6 -1.4

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

76.6

Max

79.1

Pagrindiniai rodikliai

By Trading Economics

Pajamos

25M

Pardavimai

10M

268M

P/E

Sektoriaus vid.

15.431

56.063

Dividendų pajamingumas

1.13

Pelno marža

9.734

Darbuotojai

2,497

EBITDA

252M

301M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+39.77% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

1.13%

2.45%

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-3.5M

931M

Ankstesnė atidarymo kaina

79

Ankstesnė uždarymo kaina

77.6

Naujienos nuotaikos

By Acuity

50%

50%

163 / 349 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bearish Evidence

Vetoquinol SA Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-04-01 22:56; UTC

Svarbiausios naujienos

Australian PM Set To Announce Interest-Free Loans For Businesses, Farmers

2026-04-01 20:50; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Extends Deadline on Tender Offer to Acquire Arcellx

2026-04-01 23:55; UTC

Rinkos pokalbiai

Gold Rises on Hopes for Early End to U.S.-Iran Conflict -- Market Talk

2026-04-01 23:43; UTC

Rinkos pokalbiai

Nikkei May Rise on Continued Hopes for U.S. Ending Iran War -- Market Talk

2026-04-01 23:23; UTC

Svarbiausios naujienos

South Korea Consumer Inflation Accelerates on Mideast Energy Shock -- Update

2026-04-01 23:07; UTC

Uždarbis

Shake Shack Leans on Loyalty Program and Tech to Drive Growth -- Barrons.com

2026-04-01 23:02; UTC

Svarbiausios naujienos

South Korea Consumer Inflation Accelerates on Mideast Energy Shock

2026-04-01 23:00; UTC

Svarbiausios naujienos

S Korea Mar CPI +0.3% on Month; +0.6% Forecast

2026-04-01 23:00; UTC

Svarbiausios naujienos

S Korea Mar Core CPI +2.2% on Year, +0.1% on Month

2026-04-01 23:00; UTC

Svarbiausios naujienos

S Korea Mar CPI +2.2% on Year; +2.4% Forecast

2026-04-01 22:39; UTC

Uždarbis

Nike Can't Fix Its China Problem and That's Tanking Its Stock -- Update

2026-04-01 22:08; UTC

Rinkos pokalbiai

KKR BDC Joins Others in Capping Withdrawals at 5% -- Market Talk

2026-04-01 22:00; UTC

Svarbiausios naujienos

Mideast War Rekindles Asia Inflation Risk, Says DBS Chief Economist -- Interview

2026-04-01 22:00; UTC

Svarbiausios naujienos

DBS Chief Economist: Rate Hikes Seem Likely in Japan, Singapore, Australia

2026-04-01 22:00; UTC

Svarbiausios naujienos

DBS Chief Economist: BOK Could Also Take Proactive Approach Like RBA

2026-04-01 22:00; UTC

Svarbiausios naujienos

DBS Chief Economist: India Vulnerable to War Imapct on Both Trade, Energy

2026-04-01 22:00; UTC

Svarbiausios naujienos

DBS Chief Economist: China, Malaysia Looks Relatively Well-Insulated From War Fallout

2026-04-01 22:00; UTC

Svarbiausios naujienos

DBS Chief Economist: Mideast Crisis Won't Hurt Asia Growth Much, Inflation a Bigger Issue

2026-04-01 22:00; UTC

Svarbiausios naujienos

Inflationary Impact of Mideast Conflict Seems Inevitable, DBS Group Chief Economist Says

2026-04-01 21:56; UTC

Įsigijimai, susijungimai, perėmimai

BHP Completes $4.3 Billion Silver Streaming Agreement With Wheaton Precious Metals

2026-04-01 21:31; UTC

Svarbiausios naujienos

End to Iran War Could Trigger Relief Rally in These 2 Assets -- Barrons.com

2026-04-01 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-04-01 20:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2026-04-01 20:38; UTC

Uždarbis

Why Nike Stock Is in 'Penalty Box' After Earnings Beat -- Barrons.com

2026-04-01 20:31; UTC

Įsigijimai, susijungimai, perėmimai

Arsenal Capital Partners Completes Sale of ATP Adhesive Systems to Henkel

2026-04-01 20:16; UTC

Įsigijimai, susijungimai, perėmimai

Gilead: Tender Offer Extended to Expire at 5 p.m. EDT on April 24 >GILD

2026-04-01 20:16; UTC

Įsigijimai, susijungimai, perėmimai

Gilead: Offer Remains at a Purchase Price of $115.00 per Shr >GILD

2026-04-01 20:13; UTC

Įsigijimai, susijungimai, perėmimai

Gilead Extends Tender Offer To Acquire Arcellx >GILD

2026-04-01 20:07; UTC

Rinkos pokalbiai

Mexican Manufacturing Indexes Pick Up in March -- Market Talk

2026-04-01 20:07; UTC

Įsigijimai, susijungimai, perėmimai

Why 2026 Is Biotech's Comeback Year -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Vetoquinol SA Prognozė

Kainos tikslas

By TipRanks

39.77% į viršų

12 mėnesių prognozė

Vidutinis 110 EUR  39.77%

Aukščiausias 110 EUR

Žemiausias 110 EUR

Remiantis 1 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Vetoquinol SA kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

1 ratings

1

Pirkti

0

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

72.6 / 75.1Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Bearish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Bearish Evidence

Rinkos nuotaikos

By Acuity

163 / 349 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Vetoquinol SA

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.
help-icon Live chat